Poland - Lublin: Pharmaceutical products

Release

ID (OCID): ocds-pyfy63:2021-589645
Releases: 2021-11-19 (ocds-pyfy63:2021-589645:2021-589645)
2022-03-04 (ocds-pyfy63:2021-589645:2022-114589)

Title: Poland - Lublin: Pharmaceutical products
Award criteria: ratedCriteria
Award criteria details: The most economic tender

Award criteria for item 1:
- Price (60)
- Quality: termin dostawy (40)

Award criteria for item 2:
- Price (60)
- Quality: termin dostawy (40)

Award criteria for item 3:
- Price (60)
- Quality: termin dostawy (40)

Award criteria for item 4:
- Price (60)
- Quality: termin dostawy (40)
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2022-03-04 - ?
Tenderers: Komtur Polska Sp. z o. o.
NEUCA S.A.
FARMACOL-LOGISTYKA" Sp. z o.o.
LEK Sp. A.

ID: ocds-pyfy63:2021-589645:obj:1
Classification: CPV / 33600000
Description: 1. Lenalidomidum, kaps. twarde, 10 mg, op. a 21 kaps.180 op.2. Lenalidomidum, kaps. twarde, 15 mg, op. a 21 kaps.190 op.3. Lenalidomidum, kaps. twarde, 25 mg, op. a 21 kaps.300 op.4. Lenalidomidum, kaps. twarde, 5 mg, op. a 21 kaps.60 op.

ID: ocds-pyfy63:2021-589645:obj:2
Classification: CPV / 33600000
Description: 1. Peginterferonum alfa-2a, roztwór do wstrzykiwań, 90 µg/0,5 ml, op. a 1 amp.-strz. po 0,5 ml1500 op.2. Peginterferonum alfa-2a, roztwór do wstrzykiwań, 360 μg/ml, op. a 1 amp.-strz. po 0,5 ml (+igła)150 op.

ID: ocds-pyfy63:2021-589645:obj:3
Classification: CPV / 33600000
Description: Infliximabum, proszek do sporządzania koncentratu roztworu do infuzji, 100 mg,op. a 1 fiol. 180 op.

ID: ocds-pyfy63:2021-589645:obj:4
Classification: CPV / 33600000
Description: Adalimumabum, roztwór do wstrzykiwań, 40 mg, op. a 2 amp.-strzykawka-1200 op.